Skin hydration improvement function testing verifies whether orally consumed health supplements can measurably increase skin moisture content through standardized human clinical trials. Conducted in accredited third-party laboratories operating under ISO/IEC 17025 quality systems, this evaluation combines bioinstrumental techniques such as corneometry and transepidermal water loss (TEWL) measurement with rigorous statistical analysis to generate scientifically defensible efficacy data. This article explains the testing principle, applicable sample types, test items, methodology, and regulatory applications for manufacturers seeking to substantiate skin moisture function claims.
Technical Overview
Skin hydration improvement function testing is a human-based efficacy evaluation designed to determine whether an oral health supplement, consumed at its recommended daily dosage, can significantly increase the water content of the skin, with the stratum corneum serving as the primary measurement target. Because skin moisture status is governed by the barrier function, natural moisturizing factors, and hygroscopic molecules such as hyaluronic acid, functional ingredients must be evaluated through controlled ingestion studies rather than topical application tests.
The evaluation is typically performed as a randomized, double-blind, placebo-controlled human feeding trial in accredited third-party laboratories. The core principle is to compare objective, instrument-based measurements of stratum corneum hydration between a supplement group and a placebo group over a defined intervention period, while simultaneously monitoring subject safety. In regulatory frameworks where functional foods carry approved claims, "helping to improve skin water content" is a recognized function category, and the study design must comply with the applicable national health food function evaluation programs and related GB-series technical specifications.
- Objective, instrument-based primary endpoints rather than subjective self-assessment
- Randomized, double-blind, placebo-controlled trial design to eliminate bias
- Parallel comparison against a matched placebo control group
- Integrated safety monitoring throughout the intervention period
- Statistical evaluation of within-group and between-group differences
Testing Samples
Any orally administered dietary supplement or functional food product intended to deliver a skin moisturizing or skin water content benefit can be submitted for evaluation. Samples should be provided in their final commercial formulation with a clearly defined recommended daily intake. Common sample categories include:
Collagen Peptide Products
Hydrolyzed collagen and collagen peptide powders, drinks, or tablets are among the most frequently tested products. The trial verifies whether bioactive peptides, consumed daily for the study duration, measurably elevate stratum corneum hydration and improve barrier-related parameters.
Oral Hyaluronic Acid Products
Sodium hyaluronate capsules, liquids, and chewable formulations are evaluated for their systemic moisturizing effect. Ingested hyaluronic acid is assessed for its ability to increase skin water retention as reflected in corneometer readings and TEWL reduction.
Ceramide and Skin Lipid Products
Oral ceramide, phospholipid, and essential fatty acid formulations target the intercellular lipid matrix of the stratum corneum. Testing confirms whether lipid supplementation strengthens the skin barrier and reduces insensible water loss.
Vitamin, Antioxidant, and Plant Extract Formulations
Products containing vitamin C, vitamin E, astaxanthin, polyphenols, or other antioxidant botanical extracts are tested for their capacity to support skin hydration through antioxidant and circulation-related mechanisms.
Probiotic and Composite Formulations
Testing Items
The test protocol covers both efficacy endpoints and safety indicators to ensure the complete characterization required for function claim substantiation:
- Stratum corneum water content, measured capacitively, as the primary efficacy indicator
- Transepidermal water loss (TEWL) as a key indicator of skin barrier function
- Skin surface pH and sebum secretion as supporting physiological parameters
- Skin elasticity as an optional correlative parameter where justified by product positioning
- Effective case counting and effective rate calculation for the supplement group versus the placebo group
- Safety indicators including blood pressure, heart rate, routine blood tests, routine urine tests, and liver and kidney function parameters
Testing Methods
Study Design and Subject Selection
The trial follows a randomized, double-blind, placebo-controlled parallel-group design. Eligible subjects are healthy adult volunteers with objectively confirmed dry or moisture-deficient skin and no active dermatological disease. Exclusion criteria typically cover pregnancy, lactation, use of medications affecting skin condition, recent use of moisturizing functional products, and severe systemic disorders. A common study scale is 30 to 50 evaluable subjects per group, in accordance with the applicable function evaluation program.
Instrumental Measurement Principle
Stratum corneum hydration is quantified using a capacitance-based corneometer. The probe measures the dielectric constant of the skin surface, which changes proportionally with water content in the outermost skin layers, producing reproducible arbitrary hydration units. TEWL is measured with a condenser-chamber or open-chamber probe that quantifies the vapor pressure gradient above the skin surface, reflecting barrier integrity. Both methods are non-invasive, validated bioinstrumental techniques widely recognized in skin efficacy research.
Test Procedure and Timeline
Subjects consume the test sample or an appearance-matched placebo at the recommended daily dosage for the intervention period, which is normally no shorter than 30 days and frequently extends to 60 days for slower-acting systemic ingredients. Measurements are taken at baseline, at intermediate checkpoints, and at the end of the intervention.
- Measurement environment controlled at approximately 20 to 22 degrees Celsius with relative humidity of 40 to 60 percent
- 15 to 30 minutes of acclimatization before each measurement session
- Fixed anatomical measurement sites, typically the cheek, with consistent probe placement
- Prohibition of topical skincare products and washing at the measurement site for a defined period before each reading
- Multiple readings per site with averaged results to reduce measurement variability
Data Analysis and Judgment Criteria
Results are analyzed statistically within groups (versus baseline) and between groups (supplement versus placebo). A positive result generally requires that the supplement group shows a statistically significant increase in stratum corneum water content compared with baseline, a significant difference from the placebo group at the end of the trial, and an effective rate significantly higher than that of the control group, with no adverse safety findings attributable to the sample.
Applications
Test reports from accredited third-party laboratories serve multiple commercial and regulatory purposes across the product lifecycle:
- Supporting health food registration and the approval of skin water content improvement function claims in regulated markets
- Substantiating structure and function claims on dietary supplement labels in international markets
- Providing scientific dossiers for product launches, exhibitions, and evidence-based marketing communication
- Comparing candidate formulations during research and development to guide ingredient selection and dosage optimization
- Facilitating market entry and compliance documentation for export-oriented manufacturers
- Verifying dose-response relationships and confirming the efficacy of raw material innovations
FAQ
How long does the complete test take?
The human intervention phase typically runs 30 to 60 days, and the full project cycle, including ethics review, subject recruitment, testing, and report issuance, commonly requires several months depending on subject availability and protocol complexity.
How many subjects participate in the trial?
Conventional function evaluation programs require a sufficient number of evaluable subjects, commonly 30 to 50 per group, to ensure statistical power for detecting significant differences between the supplement and placebo groups.
Why is a placebo control group necessary?
Skin moisture is influenced by season, diet, environment, and daily habits. A matched placebo group allows these confounding variables to be statistically separated from the genuine effect of the tested supplement, which is essential for credible claim substantiation.
Can the same test support both compliance and marketing?
Yes. A single well-designed trial performed in an accredited laboratory can serve as the scientific basis for regulatory submission while also providing robust data for consumer-facing efficacy communication.
What happens if safety abnormalities are observed?
All safety indicators are monitored throughout the trial. Any abnormality is clinically assessed, and results attributable to the sample may disqualify the positive efficacy conclusion, ensuring that only safe products receive functional validation.